BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12695169)

  • 1. Cyclosporin treatment in psoriatic arthritis: a cause of severe leg pain.
    Lawson CA; Fraser A; Veale DJ; Emery P
    Ann Rheum Dis; 2003 May; 62(5):489. PubMed ID: 12695169
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple haemangiomas in a psoriatic arthritis patient treated with cyclosporine.
    Flicinski J; Brzosko M; Olewniczak S
    Acta Derm Venereol; 2006; 86(3):271-2. PubMed ID: 16710599
    [No Abstract]   [Full Text] [Related]  

  • 3. Generalized pustular psoriasis following withdrawal of short-term cyclosporin therapy for psoriatic arthritis.
    Hong SB; Kim NI
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):522-3. PubMed ID: 15987319
    [No Abstract]   [Full Text] [Related]  

  • 4. Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept.
    Kamarashev J; Lor P; Forster A; Heinzerling L; Burg G; Nestle FO
    Dermatology; 2002; 205(2):213-6. PubMed ID: 12218252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A in the long-term treatment of psoriatic arthritis.
    Porzio F; Antonelli M; Antonelli S; Ceralli F; Lanciani P; Porzio V; Minisola G
    Br J Rheumatol; 1996 Dec; 35(12):1331. PubMed ID: 9010073
    [No Abstract]   [Full Text] [Related]  

  • 6. Echographic test and cyclosporin therapy in psoriatic arthritis.
    Stefano I; Eugenio R; Antonio R
    J Eur Acad Dermatol Venereol; 2000 May; 14(3):232-3. PubMed ID: 11032079
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse effects of cyclosporin a observed in rheumatoid arthritis and psoriatic arthritis].
    Prajs K; Fliciński J; Przepiera-Bedzak H; Brzosko I; Ostanek L
    Ann Acad Med Stetin; 2010; 56 Suppl 1():48-51. PubMed ID: 21365941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
    Karanikolas GN; Koukli EM; Katsalira A; Arida A; Petrou D; Komninou E; Fragiadaki K; Zacharioudaki A; Lasithiotakis I; Giavri E; Vaiopoulos G; Sfikakis PP
    J Rheumatol; 2011 Nov; 38(11):2466-74. PubMed ID: 21885499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term "cyclosporin A" therapy for psoriatic arthritis.
    Riccieri V; Sili Scavalli A; Spadaro A; Bracci M; Taccari E; Zoppini A
    Acta Derm Venereol Suppl (Stockh); 1994; 186():94-5. PubMed ID: 8073853
    [No Abstract]   [Full Text] [Related]  

  • 10. Serious pancytopenia from methotrexate treatment of psoriatic arthritis.
    Chang YC; Chen JD; Yen DH; Wang LM; Huang CI; Lee CH
    Am J Emerg Med; 2006 May; 24(3):392-4. PubMed ID: 16635735
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials.
    Mease PJ; Signorovitch J; Yu AP; Wu EQ; Gupta SR; Bao Y; Mulani PM
    Dermatology; 2010; 220(1):1-7. PubMed ID: 19940437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertriglyceridaemia during treatment with adalimumab in psoriatic arthritis.
    Stinco G; Piccirillo F; Patrone P
    Br J Dermatol; 2007 Dec; 157(6):1273-4. PubMed ID: 17916219
    [No Abstract]   [Full Text] [Related]  

  • 13. Infliximab-induced lupus-like reaction in a patient with psoriatic arthritis.
    Pallotta P; Cianchini G; Ruffelli M; Puddu P
    Rheumatology (Oxford); 2006 Jan; 45(1):116-7. PubMed ID: 16319094
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis.
    Germano V; Picchianti Diamanti A; Baccano G; Natale E; Onetti Muda A; Priori R; Valesini G
    Ann Rheum Dis; 2005 Oct; 64(10):1519-20. PubMed ID: 16162908
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute psychoses in patients with psoriatic arthritis during treatment with sulfasalazine].
    Jajić Z; Jajić I
    Reumatizam; 1998; 46(1):43-4. PubMed ID: 9921009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Active psoriatic arthritis during pregnancy: challenges and limitations of pharmacotherapy].
    Matuszewska A; Misterska-Skóra M; Wiland P
    Ann Acad Med Stetin; 2010; 56 Suppl 1():45-7. PubMed ID: 21365940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.
    Coates LC; Tillett W; Chandler D; Helliwell PS; Korendowych E; Kyle S; McInnes IB; Oliver S; Ormerod A; Smith C; Symmons D; Waldron N; McHugh NJ;
    Rheumatology (Oxford); 2013 Oct; 52(10):1754-7. PubMed ID: 23887065
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancytopenia in a patient with psoriatic arthritis treated with methotrexate and concomitant lithium.
    Maharaj AB; Chandran V
    J Rheumatol; 2015 Mar; 42(3):557. PubMed ID: 25729049
    [No Abstract]   [Full Text] [Related]  

  • 19. Transient and slight thrombocytopaenia induced by etanercept during treatment of psoriatic arthritis.
    Stinco G; Piccirillo F; Patrone P
    Acta Derm Venereol; 2008; 88(3):281-2. PubMed ID: 18480934
    [No Abstract]   [Full Text] [Related]  

  • 20. Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk?
    Lindsay K; Gough A
    Rheumatology (Oxford); 2008 Jul; 47(7):939-41. PubMed ID: 18474510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.